Author: Site Editor Publish Time: 2023-09-20 Origin: Site
Recently, API, Lacosamide, obtains CEP certificate (No. R0-CEP 2021-451-Rv 00) approved and issued by European Directorate for the Quality of Medicines & Health Care (EDQM). It signifies the high recognition of the production quality system and R&D capabilities of Shandong Loncom Pharmaceutical Co.,Ltd. by the EU Authorities. At the same time, It enhances the international competitiveness of the company and takes the company's international business to a new level.
